Back to News
Market Impact: 0.45

RPM Q2 Earnings Fall, Miss Estimates; Guides Q3, Q4; Shares Plunge

RPM
Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsAnalyst EstimatesConsumer Demand & RetailM&A & RestructuringMarket Technicals & Flows
RPM Q2 Earnings Fall, Miss Estimates; Guides Q3, Q4; Shares Plunge

RPM International reported Q2 net income attributable to stockholders of $161.21 million versus $183.20 million a year earlier, with EPS of $1.26 (adjusted EPS $1.20) missing the consensus ~$1.41 and prompting a ~5.7% pre-market share decline to $98.80. Net sales rose to $1.91 billion from $1.85 billion and reported EBIT was $228.97 million (adjusted EBIT down to $226.63M from $255.08M), while management guided Q3 sales to mid-single-digit growth and adjusted EBIT to mid- to high-single-digit growth, noting stronger consumer sales tied to acquisitions and similar mid-single-digit sales growth expected in Q4.

Analysis

Market structure: RPM’s EPS miss with rising sales signals margin compression rather than demand collapse—winners are upstream resin/pigment suppliers if cost pass-through is limited, losers are lower‑margin acquired consumer brands and small installers facing pricing pressure. Competitive dynamics favor larger incumbents (PPG, SHW) with scale pricing power, but RPM’s guidance (mid-single-digit sales, mid‑to‑high single‑digit adjusted EBIT growth) implies management expects margins to recover by Q3–Q4; market share shifts will be incremental, not structural, over 2–4 quarters. Cross-asset: equities gap lower (~5.7% pre-market) should lift short-term Treasury bids and option implied vol; higher petroleum/ethylene prices would be a direct input-cost tail risk and push RPM margins lower, while USD strength would modestly depress reported international revenue. Risk assessment: Tail risks include a failed integration of recent consumer acquisitions causing goodwill writedowns, a sharp commodity cost shock (ethylene +20% within 90 days), or a major commercial customer loss; low-probability but >10% P&L hit each. Immediate (days) risk is volatility and sentiment-driven overshoot; short-term (weeks) depends on 10‑Q/earnings call details and raw material trends; long-term (quarters) hinges on successful margin remediation and organic growth. Hidden dependencies: consumer acquisition margins, working capital build, and timing of price pass-through; catalysts: Nov–Dec housing starts, resin spot prices, RPM’s investor call in next 30–45 days. Trade implications: If you expect mean reversion, establish a tactical buy at <$100 with defined risk (stop ~‑8%), target +10–15% in 3–6 months if adjusted EBIT guidance confirmed; implement a 3‑month call spread (buy $100 / sell $115) for asymmetric upside with limited capital. For hedged exposure, run a pair trade long RPM 2% funded by short PPG 1.5% (PPG = more secularly stable pricing) to isolate company-specific recovery vs sector. Sector rotation: trim broader industrials exposure by 1–2% and overweight specialty chemicals with proven pass-through and lower raw material elasticity. Contrarian angles: Consensus fixates on the EPS miss; what may be missed is that adjusted EBIT guidance for H2 is positive and consumer growth is acquisition‑driven—short‑term dilution but potential longer‑term cash returns if integration succeeds. The market reaction may be overdone (5–6% gap) given stable sales and forward‑looking EBIT lift; historical parallels (RPM pullbacks in 2018–2019) show 6–12 month recoveries after integration bumps. Unintended consequence: buying the dip could be reversed rapidly if resin prices spike or management signals further charges on the upcoming call.